A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type 2 diabetes and peripheral artery disease (PAD), particularly those at highest risk of amputation.
| MNT RESOURCE |
 |
| How subcutaneous immunotherapy injections work |
|
|
|
| Subcutaneous immunotherapy injections for cancer treatment work the same way as intravenous infusions and are just as effective. |
| Subcutaneous immunotherapy injections for cancer treatment work the same way as intravenous infusions and are just as effective. |
|
|
READ ON  |
|
|
|
| |
|
|
| NEW PODCAST EPISODE |
|
 |
| |
|
| ADHD: Why do women get missed out? |
|
| Hosted by Maria Cohut and Yasemin Nikola Sakay |
|
| Why does it take longer for women to receive an ADHD diagnosis, and should our understanding of ADHD change? Prof. Davida Hartman, autism and ADHD specialist, joins In Conversation to answer these and other questions. |
|
|
|
|
|
|
| |
|
|
We'd love to hear from you in the meantime, so please send any feedback, comments, suggestions, or questions to the team by email.
Reminder: Add newsletter@medicalnewstoday.com to your contact list so you don’t miss a single update.
Kindly,
The Medical News Today team |
| |
|
|
| |
 |
| |
|
|
| |
| You are receiving this newsletter because you subscribed on our web site, Medical News Today. |
| Did a friend send you this email? Subscribe here. |
| View in Browser | Privacy Policy | Unsubscribe |
Our website services, content, and products are for informational purposes only. Medical News Today does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Medical News Today encourages you to make any treatment decisions with your healthcare professional. Medical News Today is owned by RVO Health.
© 2026 RVO Health
1101 Red Ventures Drive
Fort Mill, SC 29707 |
| |
|
|
|
|
Comments
Post a Comment